A domestic knowledge-based company has produced medical products that are considerably cheaper than their foreign counterparts.Kawsar Biotech Company is geared to meet domestic needs in the fields of medicine, identification and genetic testing kits, according to the company’s CEO.“The company has been able to produce a strategic medicine, i.e., the production of rabbit polyclonal antibody against human thymus,” Sirous Zeynali was also quoted as saying by the news portal of the Vice Presidency for Science and Technology.“The medicine has been marketed since the fiscal 2021-22 with the permission of the Food and Drug Administration of the Islamic Republic of Iran and the approval of the Ministry of Health and Medical Education.”The CEO noted that the company is one of five producers of molecular identification kits in the world.“In the field of genetic testing, the company has developed a variety of kits for the diagnosis of pregnancy syndromes, male infertility, peripheral joint disease [PJD] and other kinds of human diseases, which are supplied to genetic laboratories and scientific centers,” he added. Zeynali said the horse identification kit of this company is considered one of the finest domestically produced products in this field.“Since these kits are effective in diagnosing genetic diseases and determining the genetic identity of people, they are used in genetics and identification laboratories such as police and forensic medicine laboratories,” he said.“The domestic products’ prices are 4 to 10 times lower than their foreign counterparts. The price of the company’s products is four to eight times higher in the international market.”Zeynali said the company has more than 70 full-time employees and indirectly employs hundreds of people.“If supported, the medicine produced by this company can prevent the currency outflow of €6 million from importing similar products annually,” he said. (ICE TEHERAN)

Fonte notizia: Financial Tribune